Spots Global Cancer Trial Database for A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium
Official Title:
Study ID: NCT00035061
Interventions
Study Description
Brief Summary: Patients with bladder cancer will be participating in this study for the treatment of abnormal cells in the bladder that have returned after initial treatment OR have moved to a new site in the body.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Los Angeles, California, United States
, Palo Alto, California, United States
, Boca Raton, Florida, United States
, Tampa, Florida, United States
, Decatur, Illinois, United States
, Indianapolis, Indiana, United States
, Lafayette, Indiana, United States
, Muncie, Indiana, United States
, South Bend, Indiana, United States
, Lenexa, Kansas, United States
, Saint Mathews, Kentucky, United States
, Boston, Massachusetts, United States
, Omaha, Nebraska, United States
, Cleveland, Ohio, United States
, Philadelphia, Pennsylvania, United States
, Pittsburgh, Pennsylvania, United States
, Nashville, Tennessee, United States
, Fort Worth, Texas, United States
, Houston, Texas, United States
, Seattle, Washington, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
